Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update

Axsome Therapeutics (AXSM) Tops Q1 EPS by $1.03; Offers Operational Guidance

May 8, 2023 7:05 AM EDT

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($0.26), $1.03 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $28.6 million versus the consensus estimate of $25.2 million.

Axsome believes that its current cash, along with the remaining committed capital from the $350... More